Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Stock Information for Microbot Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Microbot Medical Inc.

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
Microbot Medical® Added to the Russell Microcap® Index
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.